Physician profile
Celine E Mestel
NPI 1619235306
$11,111.32
in general payments reported to CMS, 2019-2025
32 companies · $1,981 in 2025
The $1,981 reported for 2025 was more than what 75% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,184 · 2020: $745 · 2021: $1,457 · 2022: $1,396 · 2023: $2,340 · 2024: $2,008 · 2025: $1,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,220 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,220.22 |
| Education | $109.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,275.98 | 2019-2025 | |
| Janssen Biotech, INC. | $1,491.74 | 2019-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $1,277.14 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,107.93 | 2019-2025 | Ilumya, Absorica Ld, Winlevi |
| E.R. Squibb & Sons, L.L.C. | $685.29 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $623.61 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Amgen INC. | $541.63 | 2019-2025 | Otezla, Otezla |
| Genzyme Corporation | $492.84 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $401.79 | 2019-2025 | Cabtreo, Jublia |
| Regeneron Healthcare Solutions, INC. | $330.15 | 2020-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $294.57 | 2019-2025 | Adbry, Spevigo, Anzupgo |
| Galderma Laboratories, L.P. | $278.14 | 2024-2025 | Nemluvio, Aklief |
| Pfizer INC. | $275.68 | 2019-2025 | |
| Ucb, INC. | $254.65 | 2019-2025 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $181.12 | 2023-2025 | Zoryve |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $112.82 | 2022-2025 | Opzelura |
| Prugen, INC. Pharmaceuticals | $95.53 | 2019 | |
| Organogenesis INC. | $60.67 | 2023-2025 | Cygnus Dual, Puraply |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.80 | 2023-2024 | Spevigo |
| Genentech USA, INC. | $44.71 | 2019-2021 | |
| Dermavant Sciences, INC. | $44.39 | 2023 | Vtama |
| Celgene Corporation | $33.19 | 2019 | |
| Vyne Pharmaceuticals INC. | $32.62 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $22.13 | 2019 | |
| Botanix Sb INC | $21.26 | 2025 | Sofdra |
| Actelion Pharmaceuticals US, INC. | $19.57 | 2019 | |
| Biofrontera INC. | $17.54 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
| Merck Sharp & Dohme LLC | $12.14 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $11.92 | 2019 | |
| Reprise Biomedical, INC. | $11.92 | 2025 | Miro3d |
| Mission Pharmacal Company | $10.85 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celine Mestel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.